Genomic characteristics and drug screening among organoids derived from <scp>non‐small cell</scp> lung cancer patients

Abstract

Lung cancer organoid models could save precious time of drug testing on patients, and accurately select anticancer drugs according to the drug sensitivity results, so as to provide a powerful supplement and verification for the gene sequencing.